# Ablation of Intestinal Metaplasia Containing Dysplasia

> **NCT00282672** · NA · COMPLETED · sponsor: **Medtronic - MITG** · enrollment: 127 (actual)

## Conditions studied

- Barrett Esophagus

## Interventions

- **DEVICE:** Ablation System plus anti-secretory medication
- **DEVICE:** Sham procedure plus anti-secretory medication

## Key facts

- **NCT ID:** NCT00282672
- **Lead sponsor:** Medtronic - MITG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2014-04
- **Final completion:** 2014-08
- **Target enrollment:** 127 (ACTUAL)
- **Last updated:** 2017-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00282672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00282672, "Ablation of Intestinal Metaplasia Containing Dysplasia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00282672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*